Key result
A double-ballooned catheter enabling simultaneous local drug delivery and blood bypassing was successfully validated in benchtop and live pig experiments.
Why the study?
High-dose local drug treatment of cardiovascular diseases like atherosclerosis and restenosis requires extended use without causing downstream ischemia.
A novel double-ballooned catheter allows for simultaneous local drug delivery and continuous blood flow, potentially enabling extended high-dose treatments for atherosclerosis and restenosis without downstream ischemia.
Answers are grounded in this paper and cite their sources.
May enable extended local therapies without ischemia; hypothesis-generating in porcine model, human trials needed.
We present a double-ballooned catheter that enables both local drug delivery and blood bypassing at the same time. Such catheters are targeted for high-dose local drug treatment of cardiovascular diseases, such as atherosclerosis and restenosis, allowing for extended use without causing downstream ischemia. The device is composed of two flexible balloons that can isolate the lesion under inflation. Local drug delivery can be achieved using the inner catheters while a blood bypassing catheter allows for continuous blood flow. The functionalities of the catheter are validated in both benchtop and live pig experiments.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2019) studied Cardiovascular diseases (atherosclerosis and restenosis). Double-ballooned local drug delivery catheter with blood bypassing function was evaluated on Catheter functionalities (local drug delivery and blood bypassing). A double-ballooned catheter enabling simultaneous local drug delivery and blood bypassing was successfully validated in benchtop and live pig experiments.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: